BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16020216)

  • 1. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.
    Tannous ZS; Astner S
    J Cosmet Laser Ther; 2005 Mar; 7(1):39-43. PubMed ID: 16020216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic and ultrastructural analysis of melasma after fractional resurfacing.
    Goldberg DJ; Berlin AL; Phelps R
    Lasers Surg Med; 2008 Feb; 40(2):134-8. PubMed ID: 18306153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up.
    Katz TM; Glaich AS; Goldberg LH; Firoz BF; Dai T; Friedman PM
    Dermatol Surg; 2010 Aug; 36(8):1273-80. PubMed ID: 20666816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of spraying low mineral content thermal spring water after fractional photothermolysis in patients with dermal melasma.
    Barolet D; Lussier I; Mery S; Merial-Kieny C
    J Cosmet Dermatol; 2009 Jun; 8(2):114-8. PubMed ID: 19527335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
    Jang WS; Lee CK; Kim BJ; Kim MN
    Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional photothermolysis treatment for resistant melasma in Chinese females.
    Naito SK
    J Cosmet Laser Ther; 2007 Sep; 9(3):161-3. PubMed ID: 17763024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
    Polnikorn N
    J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional photothermolysis: treatment of facial and nonfacial cutaneous photodamage with a 1,550-nm erbium-doped fiber laser.
    Wanner M; Tanzi EL; Alster TS
    Dermatol Surg; 2007 Jan; 33(1):23-8. PubMed ID: 17214675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of melasma using variable square pulse Er:YAG laser resurfacing.
    Wanitphakdeedecha R; Manuskiatti W; Siriphukpong S; Chen TM
    Dermatol Surg; 2009 Mar; 35(3):475-81; discussion 481-2. PubMed ID: 19250309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional deep dermal ablation induces tissue tightening.
    Rahman Z; MacFalls H; Jiang K; Chan KF; Kelly K; Tournas J; Stumpp OF; Bedi V; Zachary C
    Lasers Surg Med; 2009 Feb; 41(2):78-86. PubMed ID: 19226572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
    Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
    J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study.
    Trelles MA; Velez M; Gold MH
    J Drugs Dermatol; 2010 Apr; 9(4):315-22. PubMed ID: 20514787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer.
    Iyer S; Friedli A; Bowes L; Kricorian G; Fitzpatrick RE
    Lasers Surg Med; 2004; 34(2):114-9. PubMed ID: 15004822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.
    Chapas AM; Brightman L; Sukal S; Hale E; Daniel D; Bernstein LJ; Geronemus RG
    Lasers Surg Med; 2008 Aug; 40(6):381-6. PubMed ID: 18649382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
    Polnikorn N
    J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional resurfacing for the treatment of hypopigmented scars: a pilot study.
    Glaich AS; Rahman Z; Goldberg LH; Friedman PM
    Dermatol Surg; 2007 Mar; 33(3):289-94; discussion 293-4. PubMed ID: 17338685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.